Nil Medical secures investment from Barncancerfonden’s new impact venture
Nil Medical AB has received its first external investment – from Barncancerfonden Impact Invest AB, a newly established impact venture launched by the Swedish Childhood Cancer Fund.
“A perfect match for us. The mission of Barncancerfonden Impact Invest aligns perfectly with our values: ensuring that any potential profit contributes to future patient benefit and supports continued research and innovation,” says Martin Hanberger, CEO and founder of Nil Medical AB.